Haemorrhagic fever with renal syndrome vaccine (Vero cells) (Liaoning Cheng Da)

肾综合征出血热疫苗（Vero细胞）

Report date: 2022/09/05 16:53:13

Base Information

Drug NameHaemorrhagic fever with renal syndrome vaccine (Vero cells) (Liaoning Cheng Da)
Drug Alias NameHFRS vaccine - Chengda
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever with Renal Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLiaoning Chengda Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Chengda Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever with Renal Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A